Zymeworks Inc.

NASDAQ:ZYME

Biotechnology

Healthcare
$26.86 -1.64%

-$0.38 today

Market cap
$1.87B
Beta
1.14
P/E (TTM)
-16.6
EPS (TTM)
-$1.37
52W Low $11.51High $29.75

Volume 0.99M

Average 0.71M

Income Statement

Follow revenue through to earnings.

Revenue

$105.97M

FY 2025 · Annual

+38.9% YoY

Operating Income

-$92.53M

FY 2025 · Annual

Net Income

-$81.13M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue26.68M412.48M76.01M76.3M105.97M
Cost of Revenue00142.99M00
Gross Profit26.68M412.48M(66.98M)76.3M105.97M
Gross Margin100.0%100.0%-88.1%100.0%100.0%
Research & Development199.75M208.6M143.62M134.62M137M
Selling, General & Admin42.6M73.4M70.4M61.5M61.5M
Operating Expenses242.31M281.95M71.08M213.41M198.5M
Depreciation & Amortization9.58M12M17.31M11.19M11.11M
EBITDA(206.09M)142.49M(120.7M)(108.62M)(68.64M)
EBITDA Margin-772.4%34.5%-158.8%-142.4%-64.8%
Operating Income(215.63M)130.53M(138.05M)(137.11M)(92.54M)
Operating Margin-808.2%31.6%-181.6%-179.7%-87.3%
Interest Income1.97M3.6M19.71M19.94M13.35M
Interest Expense00000
Other Income / Expenses3.27M4.71M18.81M20.5M12.78M
Income Before Tax(212.36M)135.23M(119.24M)(116.61M)(79.75M)
Pre-Tax Margin-795.9%32.8%-156.9%-152.8%-75.3%
Income Tax Expense(516K)10.89M(568K)6.08M1.38M
Net Income(211.84M)124.34M(118.67M)(122.7M)(81.13M)
Net Margin-794.0%30.1%-156.1%-160.8%-76.6%
EPS (Basic)(4.06)1.91(1.72)(1.62)(1.08)
EPS (Diluted)(4.61)1.90(1.72)(1.62)(1.08)
Weighted Avg Shares52.13M65.19M68.86M75.85M75.34M
Weighted Avg Shares (Diluted)52.13M65.25M68.86M75.88M75.34M

ZYME Earnings Waterfall · TTM

NASDAQ:ZYME · Revenue to Net Income

Key Ratios

EPS$0.52
Gross Margin45.9%
Net Margin-1096.4%
P/E Ratio-7.6
P/S Ratio497.1

Analysis

$266.0M of revenue converted into $43.3M of net income for the selected period. Gross margin is 45.9% and net margin is -1096.4%, showing how much revenue survives after costs and taxes. EPS is $0.52, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 9, 2026
8-K/A8-K/A filingNov 9, 2026
10-QQuarterly reportNov 9, 2026
ARSARS filingOct 26, 2026
DEFA14ADEFA14A filingOct 26, 2026

How much revenue does ZYME generate?

Zymeworks Inc. (ZYME) reported $105.97M of revenue in fiscal 2025.

Is ZYME profitable?

Zymeworks Inc. (ZYME) reported -$81.13M of net income, with a net margin of -76.6%.